Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 03. 28.
 2007³â 1Â÷ ÀÌÁ¾Àå±â(ÆǸ·,ÆǸ·µµ°ü) ¿¬±¸¹ßǥȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2007.04.18. 15:06:29   Á¶È¸: 4507
2007³â 4¿ù 17ÀÏ ¿ÀÈÄ 6½Ã-9½Ã Grand Intercontinental Hotel ¿¡¼­
2007³âµµ Á¦1Â÷ ÀÌÁ¾Àå±â ÆǸ·, ÆǸ·µµ°ü¿¬±¸ ¹ßǥȸ¸¦ °³ÃÖÇÏ¿´´Ù.
¹ßÇ¥ ¿¬Á¦;
 
1. Introduction of xenograft tissue pressrvation : ±è¿ëÁø
2. Manufacturing process & LinX Treatment of SJM  THV ;
    Mark Bullivant, Director of Marketing, Cardiac Surgery,
    ST Jude Medical International  Division
3. Detoxification of GA-fixed pericardium & Various Methods
     for in vitro material assessment " ( calcium analysis,
     thermal denaturation temperture ,amino acid analysis,
     lipid content analysis ) ; ÀÌö
4. Role of Heparin in Bioprosthesis ; ¾çÁöÇõ
5. µÅÁöÀÇ ÆǸ·¿¡¼­ galactosidase ¸¦ ÀÌ¿ëÇÑ  a-Gal epitope
      Á¦°Å ; ¹Ú¼º½Ä
6. Sterilization effect of various reagents during fixation
      ; ÃÖâÈÞ
7. Plans for lage animal valve implantation experiments for
    systemic & pulmonic position ; ±è¿õÇÑ
8. Adjourn
 
 
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 03. 28.  Àüü±Û: 211  ¹æ¹®¼ö: 1016169
194 28Â÷ ASCVTS Annual Meeting °ü¸®ÀÚ2020.02.25.5388
193 Á¦22Â÷ Update symposium °ü¸®ÀÚ2020.01.08.3847
192 Á¦8Â÷ Congenital Heart Disease Center Symposium °ü¸®ÀÚ2020.01.02.4701
191 Á¦ 51Â÷ ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2019.10.29.4704
190 Á¦33Â÷ EACTS Annual Meeting °ü¸®Áö2019.10.14.3568
189 º£Æ®³² ȣġ¹Î ÃÊ·¹À̺´¿ø ½ÉÀåÀç´ÜÀÇ·áÁö¿ø °ü¸®ÀÚ2019.09.11.3538
188 2019 APCIS & 3 day Seminar on CHD °ü¸®ÀÚ2019.06.25.3629
187 The 4th Mt. Fuji Network Forum °ü¸®ÀÚ2019.02.25.3391
186 Á¦ 55Â÷ STS Annual Meeting °ü¸®ÀÚ2019.02.07.2468
185 7th AMC CHD Center symposium °ü¸®ÀÚ2018.12.17.2135
RELOAD WRITE
[1] 2 [3] [4] [5] [6] [7] [8] [9] [10]  ¢º 22